Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7843332 | 0.78 | — | — | |
| SCHEMBL4906162 | 0.76 | — | — | |
| SCHEMBL14730570 | 0.76 | — | — | |
| SCHEMBL5172485 | 0.72 | TDP1 (0.39) | TDP1 | |
| SCHEMBL8167172 | 0.72 | — | — | |
| SCHEMBL3389327 | 0.72 | — | — | |
| SCHEMBL18886162 | 0.72 | — | — | |
| SCHEMBL1720605 | 0.68 | TDP1 (0.50) | TDP1 | |
| SCHEMBL7268897 | 0.61 | TSHR (0.44) | TDP1SMN1; SMN2 | |
| SCHEMBL94190 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1195259-B1 | Sheet for ink jet-recording | OJI PAPER CO (JP) | 2007-04-25 | — | — | EP | claimed |
| US-12618844-B2 | Cancer | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2026-05-05 | — | — | US | disclosed |
| US-20230068371-A1 | CANCER | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2023-03-02 | — | — | US | disclosed |
| US-20030134824-A1 | Beta-cyclodextrin dimers and phthalocyanines and uses thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2003-07-17 | — | — | US | disclosed |
| WO-2003052060-A2 | BETA-CYCLODEXTRIN DIMERS AND PHTHALOCYANINES AND USES THEREOF | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2003-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618844-B2 | Cancer | FABP2, CA12, CA13 | TDP1 2918/4885SMN1; SMN2 1598/4885 |
| US-20030134824-A1 | Beta-cyclodextrin dimers and phthalocyanines and uses thereof | CRY2, CRY1, HCCS | TDP1 4120/4885SMN1; SMN2 4438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.